Completed PHASE4 INTERVENTIONAL 4-arm NCT06448585

Dietary Supplement (Beta-Glucans) in Allergic Patients Undergoing Subcutaneous Immunotherapy.

Effectiveness of a Dietary Supplement Based on a Synergistic Combination of Beta-Glucans and Saccharomyces Cerevisiae Yeast Enriched With Zinc and Selenium in Allergic Patients Undergoing Subcutaneous Immunotherapy Study.

Sponsor: Gala Servicios Clinicos S.L.

Conditions Allergic Rhinoconjunctivitis Controlled Asthma Rhinitis Rhinoconjunctivitis Uncontrolled Asthma

Interventions Dietary Supplement: ABB C1 Mini-tablets with pork extract Specific immunotherapy (SIT) treatment

Updated 4 times since 2024 Last updated: Aug 23, 2025 Started: May 29, 2024 Primary completion: May 29, 2024 Completion: Dec 10, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Allergic Rhinoconjunctivitis and Controlled Asthma, this trial is completed. The trial is conducted by Gala Servicios Clinicos S.L. and has accumulated 4 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4

Status: Active Not Recruiting → Completed
Sep 2024 — Sep 2025 [monthly]

Active Not Recruiting PHASE4
Aug 2024 — Sep 2024 [monthly]

Active Not Recruiting PHASE4
Jul 2024 — Aug 2024 [monthly]

Active Not Recruiting PHASE4

First recorded

May 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gala Servicios Clinicos S.L.

Data source: Gala Servicios Clinicos S.L.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Don Benito, Spain